Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
New York AG Pushes To Prohibit Crypto Investments With Retirement Funds
-
$ETH: CME Group Shows Impeccable Timing With Launch of Its Options on Ether Futures
-
Analyst Predicts 90% Likelihood of SEC Approving Bitcoin Spot ETF by January 2024 or Earlier
-
Immunome Surges On News Of Merger With Morphimmune
-
Markets Muted Ahead Of Inflation Update